HomeProductsBuilding BlocksHeterocyclic ScaffoldsPiperidinesRimegepant
Chemical structure of CAS 1289023-67-1

Rimegepant

CAS No.1289023-67-1
MDL No.N/A
MFC28H28F2N6O3
MW534.60
InChI KeyKRNAOFGYEFKHPB-ANJVHQHFSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1289023-67-1
Product NameRimegepant

Biological Targets

CALCRL

Associated Conditions

irritable bowel syndrome·migraine disorder·psoriasis·sinusitis·temporomandibular joint disorder·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Antagonism of CGRP Signaling by Rimegepant at Two Receptors.

Frontiers in pharmacology • Vol. 11 • 2020
PMID: 32973499PMC: PMC7468408DOI: 10.3389/fphar.2020.01240

Gepants for the treatment of migraine.

Expert opinion on investigational drugs • Vol. 28, Issue 6 • 2019
PMID: 31081399DOI: 10.1080/13543784.2019.1618830

Advances in orally administered pharmacotherapy for the treatment of migraine.

Expert opinion on pharmacotherapy • Vol. 20, Issue 2 • 2019
PMID: 30475090DOI: 10.1080/14656566.2018.1549223

Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.

The New England journal of medicine • Vol. 381, Issue 2 • 2019
PMID: 31291516DOI: 10.1056/NEJMoa1811090

Documentation

Similar Products